INJECTABLE PHARMACEUTICAL FORMULATIONS
Provided herein are injectable pharmaceutical formulations, methods for their production, kits, and uses thereof in the treatment of diseases or disorders. The injectable pharmaceutical formulations include a psychopharmaceutical agent, a release modifier, and an aqueous vehicle. The pharmaceutical...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SHUKOOR, Mohammed I MORGAN, Michael E VARTY, Geoffrey B PALFREYMAN, Michael NIVOROZHKIN, Alex AVERY, Kenneth L FENG, Ju PATHARE, Pradip M |
| description | Provided herein are injectable pharmaceutical formulations, methods for their production, kits, and uses thereof in the treatment of diseases or disorders. The injectable pharmaceutical formulations include a psychopharmaceutical agent, a release modifier, and an aqueous vehicle. The pharmaceutical formulations allow for a time-restricted temporal controlled-release of the psychopharmaceutical agent upon administration by injection such as subcutaneous injection. The diseases or disorders treatable with the pharmaceutical formulations include, for example, neuropsychiatric diseases or disorders or inflammatory diseases or disorders, such as a central nervous system (CNS) disorder and/or psychological disorder, including those associated with a 5-HT2 receptor.
L'invention concerne des formulations pharmaceutiques injectables, des procédés pour leur production, des kits et leurs utilisations dans le traitement de maladies ou de troubles. Les formulations pharmaceutiques injectables comprennent un agent psychopharmaceutique, un modificateur de libération et un véhicule aqueux. Les formulations pharmaceutiques permettent une libération contrôlée temporelle limitée dans le temps de l'agent psychopharmaceutique lors de l'administration par injection telle qu'une injection sous-cutanée. Les maladies ou troubles pouvant être traités avec les formulations pharmaceutiques comprennent, par exemple, des maladies ou troubles neuropsychiatriques ou des maladies ou troubles inflammatoires, tels qu'un trouble du système nerveux central (SNC) et/ou un trouble psychologique, y compris ceux associés à un récepteur 5-HT2. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024231331A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024231331A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024231331A13</originalsourceid><addsrcrecordid>eNrjZFDz9PNydQ5xdPJxVQjwcAzydXR2DQ3xdHb0UXDzD_IN9XEM8fT3C-ZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRiZGxobGxoaOhsbEqQIAZX0kng</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INJECTABLE PHARMACEUTICAL FORMULATIONS</title><source>esp@cenet</source><creator>SHUKOOR, Mohammed I ; MORGAN, Michael E ; VARTY, Geoffrey B ; PALFREYMAN, Michael ; NIVOROZHKIN, Alex ; AVERY, Kenneth L ; FENG, Ju ; PATHARE, Pradip M</creator><creatorcontrib>SHUKOOR, Mohammed I ; MORGAN, Michael E ; VARTY, Geoffrey B ; PALFREYMAN, Michael ; NIVOROZHKIN, Alex ; AVERY, Kenneth L ; FENG, Ju ; PATHARE, Pradip M</creatorcontrib><description>Provided herein are injectable pharmaceutical formulations, methods for their production, kits, and uses thereof in the treatment of diseases or disorders. The injectable pharmaceutical formulations include a psychopharmaceutical agent, a release modifier, and an aqueous vehicle. The pharmaceutical formulations allow for a time-restricted temporal controlled-release of the psychopharmaceutical agent upon administration by injection such as subcutaneous injection. The diseases or disorders treatable with the pharmaceutical formulations include, for example, neuropsychiatric diseases or disorders or inflammatory diseases or disorders, such as a central nervous system (CNS) disorder and/or psychological disorder, including those associated with a 5-HT2 receptor.
L'invention concerne des formulations pharmaceutiques injectables, des procédés pour leur production, des kits et leurs utilisations dans le traitement de maladies ou de troubles. Les formulations pharmaceutiques injectables comprennent un agent psychopharmaceutique, un modificateur de libération et un véhicule aqueux. Les formulations pharmaceutiques permettent une libération contrôlée temporelle limitée dans le temps de l'agent psychopharmaceutique lors de l'administration par injection telle qu'une injection sous-cutanée. Les maladies ou troubles pouvant être traités avec les formulations pharmaceutiques comprennent, par exemple, des maladies ou troubles neuropsychiatriques ou des maladies ou troubles inflammatoires, tels qu'un trouble du système nerveux central (SNC) et/ou un trouble psychologique, y compris ceux associés à un récepteur 5-HT2.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241114&DB=EPODOC&CC=WO&NR=2024231331A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241114&DB=EPODOC&CC=WO&NR=2024231331A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHUKOOR, Mohammed I</creatorcontrib><creatorcontrib>MORGAN, Michael E</creatorcontrib><creatorcontrib>VARTY, Geoffrey B</creatorcontrib><creatorcontrib>PALFREYMAN, Michael</creatorcontrib><creatorcontrib>NIVOROZHKIN, Alex</creatorcontrib><creatorcontrib>AVERY, Kenneth L</creatorcontrib><creatorcontrib>FENG, Ju</creatorcontrib><creatorcontrib>PATHARE, Pradip M</creatorcontrib><title>INJECTABLE PHARMACEUTICAL FORMULATIONS</title><description>Provided herein are injectable pharmaceutical formulations, methods for their production, kits, and uses thereof in the treatment of diseases or disorders. The injectable pharmaceutical formulations include a psychopharmaceutical agent, a release modifier, and an aqueous vehicle. The pharmaceutical formulations allow for a time-restricted temporal controlled-release of the psychopharmaceutical agent upon administration by injection such as subcutaneous injection. The diseases or disorders treatable with the pharmaceutical formulations include, for example, neuropsychiatric diseases or disorders or inflammatory diseases or disorders, such as a central nervous system (CNS) disorder and/or psychological disorder, including those associated with a 5-HT2 receptor.
L'invention concerne des formulations pharmaceutiques injectables, des procédés pour leur production, des kits et leurs utilisations dans le traitement de maladies ou de troubles. Les formulations pharmaceutiques injectables comprennent un agent psychopharmaceutique, un modificateur de libération et un véhicule aqueux. Les formulations pharmaceutiques permettent une libération contrôlée temporelle limitée dans le temps de l'agent psychopharmaceutique lors de l'administration par injection telle qu'une injection sous-cutanée. Les maladies ou troubles pouvant être traités avec les formulations pharmaceutiques comprennent, par exemple, des maladies ou troubles neuropsychiatriques ou des maladies ou troubles inflammatoires, tels qu'un trouble du système nerveux central (SNC) et/ou un trouble psychologique, y compris ceux associés à un récepteur 5-HT2.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDz9PNydQ5xdPJxVQjwcAzydXR2DQ3xdHb0UXDzD_IN9XEM8fT3C-ZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRiZGxobGxoaOhsbEqQIAZX0kng</recordid><startdate>20241114</startdate><enddate>20241114</enddate><creator>SHUKOOR, Mohammed I</creator><creator>MORGAN, Michael E</creator><creator>VARTY, Geoffrey B</creator><creator>PALFREYMAN, Michael</creator><creator>NIVOROZHKIN, Alex</creator><creator>AVERY, Kenneth L</creator><creator>FENG, Ju</creator><creator>PATHARE, Pradip M</creator><scope>EVB</scope></search><sort><creationdate>20241114</creationdate><title>INJECTABLE PHARMACEUTICAL FORMULATIONS</title><author>SHUKOOR, Mohammed I ; MORGAN, Michael E ; VARTY, Geoffrey B ; PALFREYMAN, Michael ; NIVOROZHKIN, Alex ; AVERY, Kenneth L ; FENG, Ju ; PATHARE, Pradip M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024231331A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SHUKOOR, Mohammed I</creatorcontrib><creatorcontrib>MORGAN, Michael E</creatorcontrib><creatorcontrib>VARTY, Geoffrey B</creatorcontrib><creatorcontrib>PALFREYMAN, Michael</creatorcontrib><creatorcontrib>NIVOROZHKIN, Alex</creatorcontrib><creatorcontrib>AVERY, Kenneth L</creatorcontrib><creatorcontrib>FENG, Ju</creatorcontrib><creatorcontrib>PATHARE, Pradip M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHUKOOR, Mohammed I</au><au>MORGAN, Michael E</au><au>VARTY, Geoffrey B</au><au>PALFREYMAN, Michael</au><au>NIVOROZHKIN, Alex</au><au>AVERY, Kenneth L</au><au>FENG, Ju</au><au>PATHARE, Pradip M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INJECTABLE PHARMACEUTICAL FORMULATIONS</title><date>2024-11-14</date><risdate>2024</risdate><abstract>Provided herein are injectable pharmaceutical formulations, methods for their production, kits, and uses thereof in the treatment of diseases or disorders. The injectable pharmaceutical formulations include a psychopharmaceutical agent, a release modifier, and an aqueous vehicle. The pharmaceutical formulations allow for a time-restricted temporal controlled-release of the psychopharmaceutical agent upon administration by injection such as subcutaneous injection. The diseases or disorders treatable with the pharmaceutical formulations include, for example, neuropsychiatric diseases or disorders or inflammatory diseases or disorders, such as a central nervous system (CNS) disorder and/or psychological disorder, including those associated with a 5-HT2 receptor.
L'invention concerne des formulations pharmaceutiques injectables, des procédés pour leur production, des kits et leurs utilisations dans le traitement de maladies ou de troubles. Les formulations pharmaceutiques injectables comprennent un agent psychopharmaceutique, un modificateur de libération et un véhicule aqueux. Les formulations pharmaceutiques permettent une libération contrôlée temporelle limitée dans le temps de l'agent psychopharmaceutique lors de l'administration par injection telle qu'une injection sous-cutanée. Les maladies ou troubles pouvant être traités avec les formulations pharmaceutiques comprennent, par exemple, des maladies ou troubles neuropsychiatriques ou des maladies ou troubles inflammatoires, tels qu'un trouble du système nerveux central (SNC) et/ou un trouble psychologique, y compris ceux associés à un récepteur 5-HT2.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2024231331A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | INJECTABLE PHARMACEUTICAL FORMULATIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A23%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHUKOOR,%20Mohammed%20I&rft.date=2024-11-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024231331A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |